1. Home
  2. GDTC vs GNLN Comparison

GDTC vs GNLN Comparison

Compare GDTC & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.05

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$0.65

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
GNLN
Founded
2018
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Durable Goods
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
13.2M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
GDTC
GNLN
Price
$1.05
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
455.4K
233.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,275,000.00
Revenue This Year
$5.37
$1,541.21
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.01
52 Week High
$3.68
$7.73

Technical Indicators

Market Signals
Indicator
GDTC
GNLN
Relative Strength Index (RSI) 47.58 14.10
Support Level $0.87 N/A
Resistance Level $2.25 $1.80
Average True Range (ATR) 0.11 0.11
MACD 0.02 -0.00
Stochastic Oscillator 45.25 7.98

Price Performance

Historical Comparison
GDTC
GNLN

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: